These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25332665)

  • 1. Assessment of initial vancomycin dosing in neonates.
    Dersch-Mills D; Bengry T; Akierman A; Alshaikh B; Yusuf K
    Paediatr Child Health; 2014 Jun; 19(6):e30-4. PubMed ID: 25332665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of initial vancomycin dosing in neonates.
    Dersch-Mills D; Bengry T; Akierman A; Alshaikh B; Yusuf K
    Paediatr Child Health; 2014 Jun; 19(6):291. PubMed ID: 25332656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective validation of neonatal vancomycin dosing regimens is urgently needed.
    Vandendriessche A; Allegaert K; Cossey V; Naulaers G; Saegeman V; Smits A
    Curr Ther Res Clin Exp; 2014 Dec; 76():51-7. PubMed ID: 25061483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of therapeutic vancomycin trough concentrations with empirical dosing in neonatal infections.
    Lee TY; Hung YL; Shen CM; Kao CL; Hsieh WS
    Pediatr Neonatol; 2023 Mar; 64(2):176-182. PubMed ID: 36344414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Empiric Vancomycin Regimen in the Neonatal Intensive Care Unit.
    Ywaya R; Newby B
    Can J Hosp Pharm; 2019; 72(3):211-218. PubMed ID: 31258166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of initial vancomycin trough levels and risk factors of vancomycin-induced nephrotoxicity in neonates.
    Dawoud TH; Khan N; Afzal U; Varghese N; Rahmani A; Abu-Sa'da O
    Eur J Hosp Pharm; 2022 Jan; 29(1):44-49. PubMed ID: 34930794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of empiric vancomycin dosing in a neonatal population.
    Radu L; Bengry T; Akierman A; Alshaikh B; Yusuf K; Dersch-Mills D
    J Perinatol; 2018 Dec; 38(12):1702-1707. PubMed ID: 30341404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
    Reilly AM; Ding MX; Rower JE; Kiser TH
    J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between vancomycin trough concentration and area under the concentration-time curve in neonates.
    Frymoyer A; Hersh AL; El-Komy MH; Gaskari S; Su F; Drover DR; Van Meurs K
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6454-61. PubMed ID: 25136027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.
    Kim J; Walker SA; Iaboni DC; Walker SE; Elligsen M; Dunn MS; Allen VG; Simor A
    Antimicrob Agents Chemother; 2014 May; 58(5):2830-40. PubMed ID: 24614381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal.
    Tauzin M; Cohen R; Durrmeyer X; Dassieu G; Barre J; Caeymaex L
    Front Pediatr; 2019; 7():188. PubMed ID: 31139607
    [No Abstract]   [Full Text] [Related]  

  • 15. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
    Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
    J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
    Rao SC; Ahmed M; Hagan R
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose regimen for vancomycin not needing serum peak levels?
    Tan WH; Brown N; Kelsall AW; McClure RJ
    Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F214-6. PubMed ID: 12390995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily gentamicin dosing in newborn infants.
    Lundergan FS; Glasscock GF; Kim EH; Cohen RS
    Pediatrics; 1999 Jun; 103(6 Pt 1):1228-34. PubMed ID: 10353934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.